Goldman Sachs
CVS icon

Goldman Sachs’s CVS Health CVS Stock Holding History

Goldman Sachs’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$116M Sell
1,619,400
-13,800
-0.8% -$1.06M 0.01% 942
2025
Q4 		$130M Buy
1,633,200
+701,100
+75% +$55.3M 0.02% 835
2025
Q3 		$70.3M Buy
932,100
+698,300
+299% +$47.9M 0.01% 1168
2025
Q2 		$16.1M Sell
233,800
-37,800
-14% -$2.48M ﹤0.01% 2322
2025
Q1 		$18.4M Sell
271,600
-263,200
-49% -$15.8M ﹤0.01% 2113
2024
Q4 		$24M Buy
534,800
+314,800
+143% +$17.7M ﹤0.01% 1938
2024
Q3 		$13.8M Buy
220,000
+71,900
+49% +$4.19M ﹤0.01% 2398
2024
Q2 		$8.75M Buy
148,100
+10,500
+8% +$657K ﹤0.01% 2634
2024
Q1 		$11M Sell
137,600
-311,300
-69% -$23.8M ﹤0.01% 2384
2023
Q4 		$35.4M Sell
448,900
-20,000
-4% -$1.42M 0.01% 1422
2023
Q3 		$32.7M Buy
468,900
+183,900
+65% +$13M 0.01% 1393
2023
Q2 		$19.7M Buy
285,000
+151,000
+113% +$10.7M ﹤0.01% 1869
2023
Q1 		$9.96M Sell
134,000
-238,900
-64% -$20M ﹤0.01% 2425
2022
Q4 		$34.8M Buy
372,900
+44,100
+13% +$4.26M 0.01% 1464
2022
Q3 		$31.4M Sell
328,800
-125,100
-28% -$12.4M 0.01% 1475
2022
Q2 		$42.1M Sell
453,900
-308,100
-40% -$30.1M 0.01% 1247
2022
Q1 		$77.1M Sell
762,000
-140,900
-16% -$14.8M 0.02% 938
2021
Q4 		$93.1M Sell
902,900
-144,500
-14% -$13.4M 0.02% 854
2021
Q3 		$88.9M Buy
1,047,400
+191,700
+22% +$16.1M 0.02% 829
2021
Q2 		$71.4M Buy
855,700
+439,300
+105% +$36M 0.02% 977
2021
Q1 		$31.3M Sell
416,400
-292,200
-41% -$21.3M 0.01% 1552
2020
Q4 		$48.4M Buy
708,600
+305,800
+76% +$19.9M 0.01% 1148
2020
Q3 		$23.5M Sell
402,800
-10,200
-2% -$635K 0.01% 1613
2020
Q2 		$26.8M Sell
413,000
-637,400
-61% -$40.1M 0.01% 1439
2020
Q1 		$62.3M Sell
1,050,400
-217,100
-17% -$14.5M 0.02% 726
2019
Q4 		$94.2M Buy
1,267,500
+267,400
+27% +$18.8M 0.02% 726
2019
Q3 		$63.1M Buy
1,000,100
+601,700
+151% +$35.7M 0.02% 946
2019
Q2 		$21.7M Buy
398,400
+155,800
+64% +$8.39M 0.01% 1791
2019
Q1 		$13.1M Sell
242,600
-357,927
-60% -$22.1M ﹤0.01% 2209
2018
Q4 		$39.3M Sell
600,527
-862,673
-59% -$64.4M 0.01% 1259
2018
Q3 		$115M Buy
1,463,200
+1,040,800
+246% +$74.4M 0.03% 673
2018
Q2 		$27.2M Buy
422,400
+182,100
+76% +$12M 0.01% 1657
2018
Q1 		$14.9M Sell
240,300
-94,500
-28% -$6.78M ﹤0.01% 2051
2017
Q4 		$24.3M Sell
334,800
-91,900
-22% -$6.68M 0.01% 1785
2017
Q3 		$34.7M Sell
426,700
-68,100
-14% -$5.39M 0.01% 1546
2017
Q2 		$39.8M Sell
494,800
-689,700
-58% -$54.5M 0.01% 1400
2017
Q1 		$93M Buy
1,184,500
+67,800
+6% +$5.41M 0.03% 798
2016
Q4 		$88.1M Buy
1,116,700
+534,900
+92% +$43.3M 0.02% 864
2016
Q3 		$51.8M Buy
581,800
+192,100
+49% +$18.1M 0.02% 1180
2016
Q2 		$37.3M Sell
389,700
-379,500
-49% -$37.8M 0.01% 1327
2016
Q1 		$79.8M Sell
769,200
-399,400
-34% -$38.8M 0.03% 788
2015
Q4 		$114M Buy
1,168,600
+662,000
+131% +$64.8M 0.04% 595
2015
Q3 		$48.9M Sell
506,600
-222,400
-31% -$23.4M 0.02% 1071
2015
Q2 		$76.5M Buy
729,000
+201,700
+38% +$20.6M 0.02% 826
2015
Q1 		$54.4M Buy
527,300
+108,400
+26% +$11M 0.02% 1032
2014
Q4 		$40.3M Buy
418,900
+38,200
+10% +$3.37M 0.01% 1278
2014
Q3 		$30.3M Sell
380,700
-95,500
-20% -$7.53M 0.01% 1469
2014
Q2 		$35.9M Buy
476,200
+170,400
+56% +$12.9M 0.01% 1347
2014
Q1 		$22.9M Sell
305,800
-221,500
-42% -$15.6M 0.01% 1656
2013
Q4 		$37.7M Buy
527,300
+328,200
+165% +$21.1M 0.01% 1260
2013
Q3 		$11.3M Sell
199,100
-208,700
-51% -$12.4M ﹤0.01% 2131
2013
Q2 		$23.3M Buy
+407,800
New +$23.6M 0.01% 1425

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs's CVS Position: Q1 2026 in Review

Goldman Sachs increased its CVS Health (CVS) stake by 54% in Q1 2026, buying an estimated $340M and bringing the position to 12,639,801 shares worth $908M. The position accounts for 0.1% of the portfolio, ranked #184.

Goldman Sachs first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.02B in Q4 2023. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Goldman Sachs held 12,639,801 shares of CVS Health worth $908M as of Q1 2026.
  • Goldman Sachs bought 4,416,955 CVS Health shares in Q1 2026, an estimated $340M.
  • CVS Health made up 0.1% of Goldman Sachs's portfolio in Q1 2026, its #184 holding.
  • Goldman Sachs first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's CVS Health position peaked at $1.02B in Q4 2023.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.